NovoCure (NVCR) Other Working Capital Changes (2016 - 2026)
NovoCure's Other Working Capital Changes history spans 13 years, with the latest figure at -$2.8 million for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 153.08% to -$2.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$7.0 million, a 22.29% decrease, with the full-year FY2025 number at -$5.3 million, up 17.08% from a year prior.
- Other Working Capital Changes hit -$2.8 million in Q1 2026 for NovoCure, down from -$2.6 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for NVCR hit a ceiling of $920000.0 in Q2 2025 and a floor of -$3.2 million in Q1 2023.
- Historically, Other Working Capital Changes has averaged -$1.9 million across 5 years, with a median of -$1.8 million in 2024.
- Biggest five-year swings in Other Working Capital Changes: soared 150.3% in 2025 and later plummeted 153.08% in 2026.
- Tracing NVCR's Other Working Capital Changes over 5 years: stood at -$1.7 million in 2022, then dropped by 10.67% to -$1.8 million in 2023, then soared by 33.46% to -$1.2 million in 2024, then crashed by 115.05% to -$2.6 million in 2025, then fell by 7.34% to -$2.8 million in 2026.
- Business Quant data shows Other Working Capital Changes for NVCR at -$2.8 million in Q1 2026, -$2.6 million in Q4 2025, and -$2.4 million in Q3 2025.